We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$189M
AUM Growth
-$12M
Cap. Flow
-$1.6M
Cap. Flow %
-0.85%
Top 10 Hldgs %
37.05%
Holding
129
New
1
Increased
37
Reduced
59
Closed
8

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.96%
2 Technology 14.95%
3 Consumer Discretionary 14.73%
4 Healthcare 14.07%
5 Financials 13.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCG
126
DELISTED
Scana
SCG
-3,825
Closed -$205K
VTAE
127
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
-4,358
Closed -$466K

Similar funds

Rowlandmiller & Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Rowlandmiller & Partners held 129 positions worth $189M, down 6% from $201M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Rowlandmiller & Partners's Q3 2015 filing shows 1 new, 37 increased, 59 reduced and 8 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 5,929 shares worth $186K. The largest sale was VITAE PHARMACEUTICALS INC COMMON STOCK, an estimated $466K.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Rowlandmiller & Partners's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 5,929 shares worth $186K.
  • Rowlandmiller & Partners added most to Apple in Q3 2015, an estimated $648K increase.
  • Rowlandmiller & Partners's biggest Q3 2015 reduction was United Parcel Service, cutting an estimated $292K.
  • Rowlandmiller & Partners fully exited VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2015, selling an estimated $466K.
  • Rowlandmiller & Partners's ten largest holdings make up 37% of its $189M portfolio in Q3 2015.
  • Rowlandmiller & Partners opened 1 new position and closed 8 in Q3 2015.
  • Rowlandmiller & Partners's portfolio value fell 6% quarter-over-quarter to $189M.

Based on Rowlandmiller & Partners's 13F filing for Q3 2015, filed 13 Nov 2015.